"Macular Degeneration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.
| Descriptor ID |
D008268
|
| MeSH Number(s) |
C11.768.585.439
|
| Concept/Terms |
Macular Degeneration- Macular Degeneration
- Degeneration, Macular
- Degenerations, Macular
- Macular Degenerations
- Age-Related Maculopathies
- Age Related Maculopathies
- Macular Degeneration, Age-Related
- Macular Dystrophy
- Dystrophies, Macular
- Dystrophy, Macular
- Macular Dystrophies
- Maculopathies, Age-Related
- Maculopathies, Age Related
- Maculopathy, Age-Related
- Maculopathy, Age Related
- Age-Related Macular Degeneration
- Age Related Macular Degeneration
- Age-Related Macular Degenerations
- Degeneration, Age-Related Macular
- Degenerations, Age-Related Macular
- Macular Degenerations, Age-Related
- Age-Related Maculopathy
- Age Related Maculopathy
|
Below are MeSH descriptors whose meaning is more general than "Macular Degeneration".
Below are MeSH descriptors whose meaning is more specific than "Macular Degeneration".
This graph shows the total number of publications written about "Macular Degeneration" by people in this website by year, and whether "Macular Degeneration" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1997 | 2 | 0 | 2 |
| 1999 | 2 | 0 | 2 |
| 2000 | 2 | 0 | 2 |
| 2001 | 3 | 1 | 4 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 1 | 3 |
| 2014 | 4 | 1 | 5 |
| 2015 | 2 | 0 | 2 |
| 2016 | 4 | 1 | 5 |
| 2017 | 2 | 1 | 3 |
| 2018 | 4 | 0 | 4 |
| 2019 | 7 | 0 | 7 |
| 2020 | 3 | 0 | 3 |
| 2021 | 10 | 0 | 10 |
| 2022 | 8 | 0 | 8 |
| 2023 | 15 | 1 | 16 |
| 2024 | 6 | 2 | 8 |
| 2025 | 6 | 1 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Macular Degeneration" by people in Profiles.
-
Consideration of patient phenotypes in geographic atrophy due to age-related macular degeneration. BMJ Open Ophthalmol. 2025 Jul 07; 10(1).
-
Generation of induced pluripotent stem cell lines (RFSCi003-A, RFSCi004-A) from monozygotic twins discordant for age-related macular degeneration. Stem Cell Res. 2025 Sep; 87:103768.
-
Ocular Phenotyping of Knockout Mice Identifies Genes Associated With Late Adult Retinal Phenotypes. Invest Ophthalmol Vis Sci. 2025 06 02; 66(6):64.
-
Quantitative comparison of inner and outer retinal intraretinal hyperreflective foci in age-related macular degeneration. Exp Eye Res. 2025 Jul; 256:110415.
-
Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE. Am J Ophthalmol. 2025 Aug; 276:350-364.
-
Generation of human induced pluripotent stem cell lines from an age-related macular degeneration patient with hyperreflective foci overlying drusen (RFSCi002-A) and an unaffected sibling (RFSCi001-A). Stem Cell Res. 2025 Aug; 86:103715.
-
A deconvolution framework that uses single-cell sequencing plus a small benchmark data set for accurate analysis of cell type ratios in complex tissue samples. Genome Res. 2025 Jan 22; 35(1):147-161.
-
Photobiomodulation Therapy for Non-exudative Age-related Macular Degeneration. Int Ophthalmol Clin. 2025 Jan 01; 65(1):47-52.
-
Distinguishing ABCA4 from PRPH2-related disease: qualitative analysis of examination and imaging features. Ophthalmic Genet. 2025 Aug; 46(4):347-353.
-
QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age-related macular degeneration. Br J Pharmacol. 2025 Feb; 182(4):951-968.